Literature DB >> 2487404

Fibrinolytic response to standardized venous occlusion in different age groups.

S Y Hong, S J Pyo, M H Kim, S K Kim, I S Park, D Y Oh, S J Kim.   

Abstract

The purpose of this study was to find out the range and distribution of fibrinolytic response to standardized venous occlusion in healthy volunteers and to determine whether there were any differences according to age and sex. In 118 healthy volunteers (55 males, 63 females) of various age groups, the total fibrinolytic activity in euglobulin fractions was measured by a well controlled fibrin plate method before and after venous occlusion of 5 minutes at 100 mmHg. The difference between our method and previous methods is that we occluded for a relatively shorter duration than that of previous studies (15-20 minutes) at constant pressure (100 mmHg), instead of midway between systolic and diastolic pressure. This method was reliable and reproducible as a tool to qualify and assess the fibrinolytic activity capacity of individuals. The results showed that there was no difference in basal fibrinolytic activity and the response to stimuli in various age groups (p greater than 0.25) and in male and female groups (0.1 less than p less than 0.375).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487404      PMCID: PMC4534964          DOI: 10.3904/kjim.1989.4.1.48

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  20 in total

1.  The histological localisation of fibrinolysin activator.

Authors:  A S TODD
Journal:  J Pathol Bacteriol       Date:  1959-07

2.  Distribution and variation of fibrinolytic activity in the walls of human arteries and veins.

Authors:  V N Hegt
Journal:  Haemostasis       Date:  1976

3.  Natural inhibitors of fibrinolysis.

Authors:  I Juhan-Vague; M F Aillaud; A Serradimigni
Journal:  Haemostasis       Date:  1986

Review 4.  Vascular intimal components: precursors of thrombosis.

Authors:  M B Stemerman
Journal:  Prog Hemost Thromb       Date:  1974

5.  Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man.

Authors:  J D Cash; A M Gader; J da Costa
Journal:  Br J Haematol       Date:  1974-06       Impact factor: 6.998

6.  "Fibrinolytic capacity" in healthy volunteers at different ages as studied by standardized venous occlusion of arms and legs.

Authors:  B R Robertson; M Pandolfi; I M Nilsson
Journal:  Acta Med Scand       Date:  1972-03

7.  Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis.

Authors:  S Isacson; I M Nilsson
Journal:  Acta Chir Scand       Date:  1972

8.  Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading.

Authors:  P A Bolhuis; K S Sakariassen; H J Sander; B N Bouma; J J Sixma
Journal:  J Lab Clin Med       Date:  1981-04

9.  Comparison of plasminogen activator activity in human arteries and veins.

Authors:  H Ljungnér; D Bergqvist
Journal:  Thromb Res       Date:  1983-09-15       Impact factor: 3.944

10.  1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases.

Authors:  P M Mannucci; Z M Ruggeri; F I Pareti; A Capitanio
Journal:  Lancet       Date:  1977-04-23       Impact factor: 79.321

View more
  2 in total

1.  A simple quantitative assay of vascular plasminogen activator--not only stimulated fibrinolytic activity but also basal fibrinolytic activity are correlated with venous fibrinolytic activity.

Authors:  S Y Hong; C S Lee
Journal:  Korean J Intern Med       Date:  1990-07       Impact factor: 2.884

2.  Urinary plasminogen activator activity in progressive renal failure.

Authors:  S Y Hong; D H Yang
Journal:  Korean J Intern Med       Date:  1990-01       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.